Beneficial effects of cytogenetic and molecular response on long term outcome in patients with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP) treated with imatinib (IM) : update from the IRIS study

• SIMONSSON B

収録刊行物

• Blood

  Blood 106 52a-, 2005

詳細情報

• CRID: 1573950400520360832
• NII論文ID: 10030954511
• データソース種別:
  • CiNii Articles